Pacific Biosciences of Ca... (PACB)

In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.17, marking no change from the previous day.

Pacific Biosciences of California has hired Jim Gibson as its new chief financial officer, effective March 31.

Pacific Biosciences of California (PACB) reachead $1.26 at the closing of the latest trading day, reflecting a +0.8% change compared to its last close.

PACB continues to deliver growth from its unique technologies amid macroeconomic concerns.

In the closing of the recent trading day, Pacific Biosciences of California (PACB) stood at $1.22, denoting a +1.67% change from the preceding trading day.

Pacific Biosciences: Uncertain Federal Research Funding Latest Blow For Already-Battered Stock

Despite strong Service and other revenues, PacBio reports soft fourth-quarter 2024 results partly due to lower Revio system shipments.

Pacific Biosciences of California, Inc. (NASDAQ:PACB ) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Company Participants Todd Friedman - Senior Director, Finance and Investor Relation...

While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key me...

Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.20 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.27 per share a year ago.